439 related articles for article (PubMed ID: 12271373)
1. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.
Schlötzer-Schrehardt U; Viestenz A; Naumann GO; Laqua H; Michels S; Schmidt-Erfurth U
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):748-57. PubMed ID: 12271373
[TBL] [Abstract][Full Text] [Related]
2. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
Husain D; Kramer M; Kenny AG; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.
Berdugo M; Bejjani RA; Valamanesh F; Savoldelli M; Jeanny JC; Blanc D; Ficheux H; Scherz A; Salomon Y; BenEzra D; Behar-Cohen F
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1633-44. PubMed ID: 18385085
[TBL] [Abstract][Full Text] [Related]
4. [Expression of angiogenic factors by photodynamic therapy].
Rudolf M; Michels S; Schlötzer-Schrehardt U; Schmidt-Erfurth U
Klin Monbl Augenheilkd; 2004 Dec; 221(12):1026-32. PubMed ID: 15599809
[TBL] [Abstract][Full Text] [Related]
5. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor.
Schmidt-Erfurth U; Schlötzer-Schrehard U; Cursiefen C; Michels S; Beckendorf A; Naumann GO
Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4473-80. PubMed ID: 14507895
[TBL] [Abstract][Full Text] [Related]
6. Histopathological changes following photodynamic therapy in human eyes.
Schmidt-Erfurth U; Laqua H; Schlötzer-Schrehard U; Viestenz A; Naumann GO
Arch Ophthalmol; 2002 Jun; 120(6):835-44. PubMed ID: 12049594
[No Abstract] [Full Text] [Related]
7. Photodynamic therapy of experimental choroidal neovascularization in the mouse.
Odergren A; Ming Y; Kvanta A
Curr Eye Res; 2006 Sep; 31(9):765-74. PubMed ID: 16966149
[TBL] [Abstract][Full Text] [Related]
8. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
Schmidt-Erfurth UM; Michels S
Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of circumscribed choroidal hemangioma.
Porrini G; Giovannini A; Amato G; Ioni A; Pantanetti M
Ophthalmology; 2003 Apr; 110(4):674-80. PubMed ID: 12689885
[TBL] [Abstract][Full Text] [Related]
10. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.
Mori K; Yoneya S; Anzail K; Kabasawa S; Sodeyama T; Peyman GA; Moshfeghi DM
Retina; 2001; 21(5):499-508. PubMed ID: 11642380
[TBL] [Abstract][Full Text] [Related]
13. Effects of photodynamic therapy on the choriocapillaris and retinal pigment epithelium in the irradiated area.
Dewi NA; Yuzawa M; Tochigi K; Kawamura A; Mori R
Jpn J Ophthalmol; 2008; 52(4):277-281. PubMed ID: 18773265
[TBL] [Abstract][Full Text] [Related]
14. Sequence of early vascular events after photodynamic therapy.
Michels S; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2147-54. PubMed ID: 12714655
[TBL] [Abstract][Full Text] [Related]
15. Choriocapillaris photodynamic therapy using indocyanine green.
Costa RA; Farah ME; Freymüller E; Morales PH; Smith R; Cardillo JA
Am J Ophthalmol; 2001 Oct; 132(4):557-65. PubMed ID: 11589879
[TBL] [Abstract][Full Text] [Related]
16. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey.
Reinke MH; Canakis C; Husain D; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
Ophthalmology; 1999 Oct; 106(10):1915-23. PubMed ID: 10519585
[TBL] [Abstract][Full Text] [Related]
17. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
Mori K; Yoneya S; Ohta M; Sano A; Anzai K; Peyman GA; Moshfeghi DM
Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627
[TBL] [Abstract][Full Text] [Related]
18. Retreatment effect of NPe6 photodynamic therapy on the normal primate macula.
Nakashizuka T; Mori K; Hayashi N; Anzail K; Kanail K; Yoneya S; Moshfeghi DM; Peyman GA
Retina; 2001; 21(5):493-8. PubMed ID: 11642379
[TBL] [Abstract][Full Text] [Related]
19. [A new approach for studying the retinal and choroidal circulation].
Yoneya S
Nippon Ganka Gakkai Zasshi; 2004 Dec; 108(12):836-61; discussion 862. PubMed ID: 15656089
[TBL] [Abstract][Full Text] [Related]
20. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.
Zacks DN; Ezra E; Terada Y; Michaud N; Connolly E; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2384-91. PubMed ID: 12091441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
